Discussion: These findings suggest that the MMP-inducer EMMPRIN and the extracellular matrix degrading systeminvolving the metalloproteinases MMP-2 and MT1-MMP is frequently activated in mesenchymal tumors. The gene discussed is MMP2; the disease is mesenchymal cell neoplasm.